Biocryst Pharmaceuticals Inc (BCRX)
8.88
-0.12 -1.33%
NASDAQ
Feb 19, 13:52
Delayed 2m
USD
Biocryst Pharmaceuticals Inc Normalized Income (Quarterly)
View 4,000+ financial data types
Browse...
View Full Chart
Biocryst Pharmaceuticals Inc Normalized Income (Quarterly) Chart
Biocryst Pharmaceuticals Inc Historical Normalized Income (Quarterly) Data
View and export this data going back to 1994.
Start your Free Trial
Export Data
Date Range:
Data for this Date Range | |
---|---|
Sept. 30, 2018 | Upgrade |
June 30, 2018 | Upgrade |
March 31, 2018 | Upgrade |
Dec. 31, 2017 | Upgrade |
Sept. 30, 2017 | Upgrade |
June 30, 2017 | Upgrade |
March 31, 2017 | Upgrade |
Dec. 31, 2016 | Upgrade |
Sept. 30, 2016 | Upgrade |
June 30, 2016 | Upgrade |
March 31, 2016 | Upgrade |
Dec. 31, 2015 | Upgrade |
Sept. 30, 2015 | Upgrade |
June 30, 2015 | Upgrade |
March 31, 2015 | Upgrade |
Dec. 31, 2014 | Upgrade |
Sept. 30, 2014 | Upgrade |
June 30, 2014 | Upgrade |
March 31, 2014 | Upgrade |
Dec. 31, 2013 | Upgrade |
Sept. 30, 2013 | Upgrade |
June 30, 2013 | Upgrade |
March 31, 2013 | Upgrade |
Dec. 31, 2012 | Upgrade |
Sept. 30, 2012 | Upgrade |
June 30, 2012 | Upgrade |
March 31, 2012 | Upgrade |
Dec. 31, 2011 | Upgrade |
Sept. 30, 2011 | Upgrade |
June 30, 2011 | Upgrade |
March 31, 2011 | Upgrade |
Dec. 31, 2010 | Upgrade |
Sept. 30, 2010 | Upgrade |
June 30, 2010 | Upgrade |
March 31, 2010 | Upgrade |
Dec. 31, 2009 | Upgrade |
Sept. 30, 2009 | Upgrade |
June 30, 2009 | Upgrade |
March 31, 2009 | Upgrade |
Dec. 31, 2008 | Upgrade |
Sept. 30, 2008 | Upgrade |
June 30, 2008 | Upgrade |
March 31, 2008 | Upgrade |
Dec. 31, 2007 | Upgrade |
Sept. 30, 2007 | Upgrade |
June 30, 2007 | Upgrade |
March 31, 2007 | Upgrade |
Dec. 31, 2006 | Upgrade |
Sept. 30, 2006 | Upgrade |
June 30, 2006 | Upgrade |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Normalized Income
Normalized Income is the company's income after removing expenses and revenue that are not recurring. Normalized income gives investors a better idea of the company's income in a "normal" year.
Learn More
View Normalized Income (Quarterly) for BCRX
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.
Start My Free Trial
No credit card required.
Already a subscriber? Sign in.
BCRX Normalized Income (Quarterly) Benchmarks
Benchmarks | |
---|---|
Becton, Dickinson and Co | Upgrade |
Stemline Therapeutics Inc | Upgrade |
TransEnterix Inc | Upgrade |
BCRX Normalized Income (Quarterly) Range, Past 5 Years
Minimum | Upgrade | Sep 2018 |
Maximum | Upgrade | Jun 2015 |
Average | Upgrade |
BCRX Normalized Income (Quarterly) Excel Add-In Codes
- Metric Code: normalized_income
- Latest data point: =YCP("BCRX", "normalized_income")
- Last 5 data points: =YCS("BCRX", "normalized_income", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
BCRX News
BioCryst to Report Fourth Quarter and Full Year 2018 Financial Results on March 4
Globe Newswire 02/18 07:00 ET
Globe Newswire 02/18 07:00 ET
BioCryst Pharmaceuticals Triples Size of Secured Loan Facility to $100 Mln
MT Newswires 02/06 07:38 ET
MT Newswires 02/06 07:38 ET
BioCryst Strengthens Cash Position With Flexible $100 Million Debt Facility
Globe Newswire 02/06 07:00 ET
Globe Newswire 02/06 07:00 ET
BioCryst to Present ZENITH-1 Results at American Academy of Allergy, Asthma & Immunology Annual Meeting
Globe Newswire 02/05 07:00 ET
Globe Newswire 02/05 07:00 ET